Skip to main content

Table 3 COX regression for AAV complicated infection

From: Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study

 

Single factor analysis

Multiple factor analysis

varium

HR (95% CI)

P

HR (95% CI)

P

Age

1.004 (1.001–1.007)

0.008

1.003 (1.000–1.006)

0.030

gender

1.444 (0.938–2.221)

0.095

0.723 (0.394–1.328)

0.296

smoking

2.293 (1.465–3.588)

0.000

2.338 (1.236–4.424)

0.009

Diabetes

1.504 (0.651–3.474)

0.339

  

Hemoglobin< 7.75 g/dl

2.079 (1.358–3.182)

0.001

1.362 (0.827–2.243)

0.224

Albumin< 33.95 g/l

1.902 (1.243–2.910)

0.003

1.178 (0.740–1.874)

0.490

baseline creatinine higher than 5.74 mg/dl

3.190 (2.053–4.957)

0.000

2.153 (1.323–3.502)

0.002

CD4+T cell< 281/ul

02.021 (1.316–3.105)

0.001

1.813 (1.133–2.900)

0.013

BVAS at the time of diagnosis > 25.5

1.883 (0.815–4.349)

0.138

  

corticosteroids+MMF

1.945 (1.156–3.272)

0.012

1.004 (0.571–1.765)

0.989

corticosteroids+CYC

1.906 (1.073–3.383)

0.028

1.951 (1.520–2.740)

0.042

corticosteroids+TW

1.519 (1.110–2.715)

0.042

0.572 (0.262–1.250)

0.161

  1. MP Methlyprednisone, MMF mycophenolate mofetil, CYC cyclophosphamide, TW Tripterygium wilfordii